- Home
- IPW vs NEPH Comparison
IPW vs NEPH Comparison
Compare IPW & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- NEPH
- Stock Information
- Founded
- IPW 2018
- NEPH 1997
- Country
- IPW United States
- NEPH United States
- Employees
- IPW N/A
- NEPH N/A
- Industry
- IPW Catalog/Specialty Distribution
- NEPH Medical/Dental Instruments
- Sector
- IPW Consumer Discretionary
- NEPH Health Care
- Exchange
- IPW Nasdaq
- NEPH Nasdaq
- Market Cap
- IPW 15.7M
- NEPH 16.8M
- IPO Year
- IPW 2021
- NEPH 2004
- Fundamental
- Price
- IPW $0.66
- NEPH $3.36
- Analyst Decision
- IPW Strong Buy
- NEPH Buy
- Analyst Count
- IPW 1
- NEPH 1
- Target Price
- IPW $2.75
- NEPH $5.00
- AVG Volume (30 Days)
- IPW 531.4K
- NEPH 29.4K
- Earning Date
- IPW 05-15-2025
- NEPH 05-08-2025
- Dividend Yield
- IPW N/A
- NEPH N/A
- EPS Growth
- IPW N/A
- NEPH N/A
- EPS
- IPW N/A
- NEPH 0.08
- Revenue
- IPW $74,105,251.00
- NEPH $15,517,000.00
- Revenue This Year
- IPW $8.31
- NEPH $17.06
- Revenue Next Year
- IPW $77.15
- NEPH $12.20
- P/E Ratio
- IPW N/A
- NEPH $44.39
- Revenue Growth
- IPW N/A
- NEPH 10.34
- 52 Week Low
- IPW $0.41
- NEPH $1.36
- 52 Week High
- IPW $3.65
- NEPH $3.66
- Technical
- Relative Strength Index (RSI)
- IPW 67.58
- NEPH 75.39
- Support Level
- IPW $0.43
- NEPH $3.26
- Resistance Level
- IPW $0.94
- NEPH $3.66
- Average True Range (ATR)
- IPW 0.10
- NEPH 0.28
- MACD
- IPW 0.01
- NEPH 0.08
- Stochastic Oscillator
- IPW 44.29
- NEPH 81.37
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.